PTPRC and chronic obstructive pulmonary disease: We observed that the numbers of immune cells (CD45+) are increased in COPD patients who do not use ICS compared to both smoking controls and COPD patients using ICS; confirming that ICS reduce immune cell infiltration in COPD patients.